HER2 Support Group Forums - View Single Post - Phase 1 clinical trial of poliovirus therapy shows long-term survival benefit for rec

News · 06-26-2018, 07:13 AM

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate of 21 percent in a phase 1 clinical trial.

More...

06-26-2018, 07:13 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,983	Phase 1 clinical trial of poliovirus therapy shows long-term survival benefit for rec A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate of 21 percent in a phase 1 clinical trial. More...